INCOME STATEMENT
Zenith Drugs Ltd.
NSE
Jun 13
66.25
-2.15 ( -3.14%)
Volume
4000
Prev. Close
68.40
Open Price
68.35
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Income Statement
for the last 5 years.
ISIN No
|
INE0QWN01013
|
Market Cap. ( ₹ in Cr. )
|
113.61
|
P/BV
|
1.83
|
Book Value ( ₹ )
|
36.28
|
BSE Code
|
-
|
52 Week High/Low ( ₹ )
|
154/47
|
FV/ML
|
10/800
|
P/E(X)
|
15.87
|
NSE Code
|
ZENITHDRUGST
|
Book Closure
|
25/09/2024
|
EPS ( ₹ )
|
4.18
|
Div Yield (%)
|
0.00
|
(₹ in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Gross] | 133.32 | 150.36 | 128.16 | 91.66 | 73.40 |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 18.74 | 13.64 | 0.00 | 0.00 |
Revenue From Operations [Net] | 133.32 | 131.62 | 114.52 | 91.66 | 73.40 |
Total Operating Revenues | 133.32 | 131.62 | 114.52 | 91.66 | 73.40 |
| | | | | |
Other Income | 2.61 | 2.12 | 1.24 | 0.95 | 0.11 |
Total Revenue | 135.93 | 133.74 | 115.76 | 92.60 | 73.52 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 88.07 | 84.15 | 78.66 | 69.19 | 47.69 |
Operating And Direct Expenses | 0.00 | 7.90 | 7.00 | 6.25 | 4.57 |
Changes In Inventories Of FG,WIP And Stock-In Trade | -0.59 | 1.36 | -0.54 | -2.93 | 0.16 |
Employee Benefit Expenses | 7.33 | 6.09 | 4.96 | 3.85 | 3.48 |
Finance Costs | 3.71 | 3.00 | 2.33 | 2.14 | 1.49 |
Depreciation And Amortisation Expenses | 2.97 | 1.30 | 1.30 | 1.34 | 1.22 |
Other Expenses | 24.93 | 15.21 | 15.38 | 8.37 | 10.31 |
Total Expenses | 126.42 | 119.00 | 109.10 | 88.20 | 68.92 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 9.51 | 14.74 | 6.66 | 4.40 | 4.60 |
| | | | | |
Exceptional Items | -0.25 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit/Loss Before Tax | 9.26 | 14.74 | 6.66 | 4.40 | 4.60 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 2.10 | 3.85 | 1.76 | 1.25 | 1.36 |
Deferred Tax | 0.00 | -0.24 | -0.05 | -0.05 | 0.17 |
Tax For Earlier Years | 0.00 | 0.14 | 0.07 | 0.00 | 0.00 |
Total Tax Expenses | 2.10 | 3.76 | 1.78 | 1.19 | 1.53 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 7.16 | 10.99 | 4.88 | 3.21 | 3.07 |
| | | | | |
Extraordinary Items | 0.00 | -1.45 | 0.00 | 0.00 | 0.00 |
Profit/Loss From Continuing Operations | 7.16 | 9.54 | 4.88 | 3.21 | 3.07 |
| | | | | |
Profit/Loss For The Period | 7.16 | 9.54 | 4.88 | 3.21 | 3.07 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | 4.18 | 5.56 | 122.03 | 80.32 | 76.66 |
Diluted EPS (Rs.) | 4.18 | 5.56 | 122.03 | 80.32 | 76.66 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 0.00 | 0.86 | 0.00 | 0.00 | 0.00 |
Equity Dividend Rate (%) | 0.00 | 5.00 | 0.00 | 0.00 | 0.00 |